Introduced in the treatment of urinary incontinence caused by stroke

Mark
Written By Mark

A report published in the journal (Stroke) stated that studies depend on brain imaging that allow researchers better for the cause of incontinence after exposure to a stroke, and this may help to reach ways for treatment that re -control the bladder in these patients.

The researchers wrote in the report published Thursday that up to 79% of patients are subjected to urine incontinence immediately after stroke, and the problem continues in nearly 40% of survivors for a year.

“The brain plays an important role in organizing the work of the bladder, and this enables people to feel full of bladder and gives them the ability to delay urination … or urinate as desired,” said the head of the study, Dr. Yafjini Kredine of the Cake College of Medicine at the University of Southern California.

“Survivors of a stroke often suffer from difficulty in curbing unwanted bladder contractions, and they may completely lose sensation and awareness. Because stroke affects the brain, it disrupts the natural (nervous) paths that regulate the control of the bladder.”

The study team conducted a magnetic resonance imaging of brain function in patients who suffered a stroke, suffer from urinary incontinence and healthy volunteers during the bladder fullness and emptying it frequently.

advertisement

When the participants decided to empty their bladder, both healthy and survivors of stroke witnessed a great activity in the brain areas associated with motor sensory control and executive decisions.

In contrast, during the emptying of the involuntary bladder in the survivors of the stroke, the researchers noticed a small activity in the brain shell, and this indicates that the main brain networks needed to control urination.

The researchers said this discovery opens the doors to possible treatment interventions.

These solutions may include non -surgical techniques for stimulating the brain, such as magnetic stimulation or direct stimulation, or developing drugs that promote stimulating control areas of urination in the brain.